Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › BioMérieux Reports 10 Percent Revenue Growth in Q4

BioMérieux Reports 10 Percent Revenue Growth in Q4

Feb 27, 2019
|
staff reporter

NEW YORK (GenomeWeb) – BioMérieux reported today that its fourth quarter revenues rose 10 percent year over year both on a reported and adjusted basis.

For the three months ended Dec. 31, BioMérieux reported revenues of €672.4 million ($765.6 million), up from €613.8 million in the prior-year period.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jul
23
Featured Webinar

Clinical Utility of Liquid Biopsy for the Detection of T790M to Guide Lung Cancer Treatment Strategy

This webinar will discuss a study that set to assess the efficacy and safety of osimertinib in EGFR T790M positive non-small cell lung cancer (NSCLC) patients identified by using plasma sample and cobas EGFR Mutation test v2. This is the first prospective study to use liquid biopsy upfront to evaluate osimertinib efficacy.

Aug
19
Featured Webinar

Case Study: An IVD Manufacturer’s Experience Building a Complete Sample-to-Result Workflow

Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.

What's Popular?

In PCR

  1. SARS-CoV-2 Pandemic May Promote Progress in Paper MDx

  2. FDA Grants EUA for UCSF, Broad Institute, BioSewoom Coronavirus Tests

  3. Vela Diagnostics Automated Coronavirus Test Gets CE-IVD Mark

  4. Helix, San Diego County Partner on COVID-19 Molecular Testing

  5. FDA Grants EUAs for Boston Medical Center, Beijing Wantai Biological Pharmacy Coronavirus Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.